Broadfin Capital’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Broadfin Capital’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,597	Closed	-$444K	–	75
2016 Q2	$444K	Sell	5,597 -52,650	-90%	-$4.56M	0.04%	70
2016 Q1	$4.43M	Hold	58,247	–	–	0.43%	50
2015 Q4	$5.22M	Hold	58,247	–	–	0.32%	64
2015 Q3	$6.52M	Sell	58,247 -1,128	-2%	-$130K	0.36%	61
2015 Q2	$6.04M	Hold	59,375	–	–	0.32%	67
2015 Q1	$6.48M	Hold	59,375	–	–	0.5%	53
2014 Q4	$5.41M	Hold	59,375	–	–	0.47%	47
2014 Q3	$4.73M	Hold	59,375	–	–	0.5%	50
2014 Q2	$4.61M	Buy	59,375 +1,900	+3%	+$148K	0.45%	53
2014 Q1	$4.63M	Buy	+57,475	New	+$5.27M	0.45%	53

Other funds holding PLXP

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

TCM

Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Broadfin Capital's PLXP Position: Q3 2016 in Review

Broadfin Capital sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2016, closing a stake of 5,597 shares — an estimated $444K sold.

Broadfin Capital first reported a position in PLXP in Q1 2014 and held it in 10 quarters. The position peaked at $6.52M in Q3 2015. 32 funds tracked by Wall St. Rank hold PLXP as of Q3 2016.

Broadfin Capital reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Broadfin Capital sold 5,597 PLx Pharma Inc. Common Stock shares in Q3 2016, an estimated $444K.
Broadfin Capital first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 10 quarters.
Broadfin Capital's PLx Pharma Inc. Common Stock position peaked at $6.52M in Q3 2015.
32 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2016.

Based on Broadfin Capital's 13F filing for Q3 2016, filed 14 Nov 2016.